Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Haemostat Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Haemostat Market Outlook, In‑Depth Analysis & Forecast to 2031
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Haemostat market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Haemostat market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
- Ethicon
- CSL Behring
- Pfizer
- Equimedical BV
- Davol
- Baxter
- Hemcon Medical Technologies
- Ceremed
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Pituitrin
- Hemostatic Sensitivity
- Others
Segment by Application
- Hospital
- Clinic
- ASCs
- Others
Chapter Outline
Chapter 1: Defines the Haemostat study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Study Coverage
1.1 Introduction to Haemostat: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Haemostat Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Pituitrin
1.2.3 Hemostatic Sensitivity
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Haemostat Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 ASCs
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Haemostat Revenue Estimates and Forecasts 2020-2031
2.2 Global Haemostat Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Haemostat Sales Estimates and Forecasts 2020-2031
2.4 Global Haemostat Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Haemostat Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Haemostat Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Pituitrin Market Size by Manufacturers
3.5.2 Hemostatic Sensitivity Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Haemostat Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Haemostat Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Haemostat Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Haemostat Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Haemostat Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Haemostat Sales and Revenue by Type (2020-2031)
6.4 North America Haemostat Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Haemostat Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Haemostat Sales and Revenue by Type (2020-2031)
7.4 Europe Haemostat Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Haemostat Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Haemostat Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Haemostat Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Haemostat Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Haemostat Sales and Revenue by Type (2020-2031)
9.4 Central and South America Haemostat Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Haemostat Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Haemostat Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Haemostat Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Haemostat Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Ethicon
11.1.1 Ethicon Corporation Information
11.1.2 Ethicon Business Overview
11.1.3 Ethicon Haemostat Product Models, Descriptions and Specifications
11.1.4 Ethicon Haemostat Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Ethicon Haemostat Sales by Product in 2024
11.1.6 Ethicon Haemostat Sales by Application in 2024
11.1.7 Ethicon Haemostat Sales by Geographic Area in 2024
11.1.8 Ethicon Haemostat SWOT Analysis
11.1.9 Ethicon Recent Developments
11.2 CSL Behring
11.2.1 CSL Behring Corporation Information
11.2.2 CSL Behring Business Overview
11.2.3 CSL Behring Haemostat Product Models, Descriptions and Specifications
11.2.4 CSL Behring Haemostat Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 CSL Behring Haemostat Sales by Product in 2024
11.2.6 CSL Behring Haemostat Sales by Application in 2024
11.2.7 CSL Behring Haemostat Sales by Geographic Area in 2024
11.2.8 CSL Behring Haemostat SWOT Analysis
11.2.9 CSL Behring Recent Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Haemostat Product Models, Descriptions and Specifications
11.3.4 Pfizer Haemostat Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Pfizer Haemostat Sales by Product in 2024
11.3.6 Pfizer Haemostat Sales by Application in 2024
11.3.7 Pfizer Haemostat Sales by Geographic Area in 2024
11.3.8 Pfizer Haemostat SWOT Analysis
11.3.9 Pfizer Recent Developments
11.4 Equimedical BV
11.4.1 Equimedical BV Corporation Information
11.4.2 Equimedical BV Business Overview
11.4.3 Equimedical BV Haemostat Product Models, Descriptions and Specifications
11.4.4 Equimedical BV Haemostat Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Equimedical BV Haemostat Sales by Product in 2024
11.4.6 Equimedical BV Haemostat Sales by Application in 2024
11.4.7 Equimedical BV Haemostat Sales by Geographic Area in 2024
11.4.8 Equimedical BV Haemostat SWOT Analysis
11.4.9 Equimedical BV Recent Developments
11.5 Davol
11.5.1 Davol Corporation Information
11.5.2 Davol Business Overview
11.5.3 Davol Haemostat Product Models, Descriptions and Specifications
11.5.4 Davol Haemostat Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Davol Haemostat Sales by Product in 2024
11.5.6 Davol Haemostat Sales by Application in 2024
11.5.7 Davol Haemostat Sales by Geographic Area in 2024
11.5.8 Davol Haemostat SWOT Analysis
11.5.9 Davol Recent Developments
11.6 Baxter
11.6.1 Baxter Corporation Information
11.6.2 Baxter Business Overview
11.6.3 Baxter Haemostat Product Models, Descriptions and Specifications
11.6.4 Baxter Haemostat Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Baxter Recent Developments
11.7 Hemcon Medical Technologies
11.7.1 Hemcon Medical Technologies Corporation Information
11.7.2 Hemcon Medical Technologies Business Overview
11.7.3 Hemcon Medical Technologies Haemostat Product Models, Descriptions and Specifications
11.7.4 Hemcon Medical Technologies Haemostat Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Hemcon Medical Technologies Recent Developments
11.8 Ceremed
11.8.1 Ceremed Corporation Information
11.8.2 Ceremed Business Overview
11.8.3 Ceremed Haemostat Product Models, Descriptions and Specifications
11.8.4 Ceremed Haemostat Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Ceremed Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Haemostat Industry Chain
12.2 Haemostat Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Haemostat Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Haemostat Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Haemostat Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Haemostat Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
Table of Figures
List of Tables
Table 1. Global Haemostat Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Haemostat Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Haemostat Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Haemostat Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Haemostat Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Haemostat Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Haemostat Sales by Region (2020-2025) & (K Units)
Table 8. Global Haemostat Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Haemostat Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Haemostat Sales Share by Manufacturers (2020-2025)
Table 12. Global Haemostat Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Haemostat Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Haemostat by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemostat as of 2024)
Table 16. Global Haemostat Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Haemostat Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/Unit)
Table 18. Key Manufacturers Haemostat Manufacturing Base and Headquarters
Table 19. Global Haemostat Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Haemostat Sales by Type (2020-2025) & (K Units)
Table 23. Global Haemostat Sales by Type (2026-2031) & (K Units)
Table 24. Global Haemostat Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Haemostat Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Haemostat ASP by Type (2020-2031) & (USD/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Haemostat Sales by Application (2020-2025) & (K Units)
Table 29. Global Haemostat Sales by Application (2026-2031) & (K Units)
Table 30. Haemostat High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Haemostat Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Haemostat Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Haemostat ASP by Application (2020-2031) & (USD/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Haemostat Growth Accelerators and Market Barriers
Table 37. North America Haemostat Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Haemostat Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Haemostat Growth Accelerators and Market Barriers
Table 40. Europe Haemostat Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Haemostat Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Haemostat Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Haemostat Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Haemostat Growth Accelerators and Market Barriers
Table 45. Southeast Asia Haemostat Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Haemostat Investment Opportunities and Key Challenges
Table 47. Central and South America Haemostat Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Haemostat Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Haemostat Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Ethicon Corporation Information
Table 51. Ethicon Description and Major Businesses
Table 52. Ethicon Product Models, Descriptions and Specifications
Table 53. Ethicon Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 54. Ethicon Sales Value Proportion by Product in 2024
Table 55. Ethicon Sales Value Proportion by Application in 2024
Table 56. Ethicon Sales Value Proportion by Geographic Area in 2024
Table 57. Ethicon Haemostat SWOT Analysis
Table 58. Ethicon Recent Developments
Table 59. CSL Behring Corporation Information
Table 60. CSL Behring Description and Major Businesses
Table 61. CSL Behring Product Models, Descriptions and Specifications
Table 62. CSL Behring Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. CSL Behring Sales Value Proportion by Product in 2024
Table 64. CSL Behring Sales Value Proportion by Application in 2024
Table 65. CSL Behring Sales Value Proportion by Geographic Area in 2024
Table 66. CSL Behring Haemostat SWOT Analysis
Table 67. CSL Behring Recent Developments
Table 68. Pfizer Corporation Information
Table 69. Pfizer Description and Major Businesses
Table 70. Pfizer Product Models, Descriptions and Specifications
Table 71. Pfizer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Pfizer Sales Value Proportion by Product in 2024
Table 73. Pfizer Sales Value Proportion by Application in 2024
Table 74. Pfizer Sales Value Proportion by Geographic Area in 2024
Table 75. Pfizer Haemostat SWOT Analysis
Table 76. Pfizer Recent Developments
Table 77. Equimedical BV Corporation Information
Table 78. Equimedical BV Description and Major Businesses
Table 79. Equimedical BV Product Models, Descriptions and Specifications
Table 80. Equimedical BV Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Equimedical BV Sales Value Proportion by Product in 2024
Table 82. Equimedical BV Sales Value Proportion by Application in 2024
Table 83. Equimedical BV Sales Value Proportion by Geographic Area in 2024
Table 84. Equimedical BV Haemostat SWOT Analysis
Table 85. Equimedical BV Recent Developments
Table 86. Davol Corporation Information
Table 87. Davol Description and Major Businesses
Table 88. Davol Product Models, Descriptions and Specifications
Table 89. Davol Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Davol Sales Value Proportion by Product in 2024
Table 91. Davol Sales Value Proportion by Application in 2024
Table 92. Davol Sales Value Proportion by Geographic Area in 2024
Table 93. Davol Haemostat SWOT Analysis
Table 94. Davol Recent Developments
Table 95. Baxter Corporation Information
Table 96. Baxter Description and Major Businesses
Table 97. Baxter Product Models, Descriptions and Specifications
Table 98. Baxter Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 99. Baxter Recent Developments
Table 100. Hemcon Medical Technologies Corporation Information
Table 101. Hemcon Medical Technologies Description and Major Businesses
Table 102. Hemcon Medical Technologies Product Models, Descriptions and Specifications
Table 103. Hemcon Medical Technologies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Hemcon Medical Technologies Recent Developments
Table 105. Ceremed Corporation Information
Table 106. Ceremed Description and Major Businesses
Table 107. Ceremed Product Models, Descriptions and Specifications
Table 108. Ceremed Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 109. Ceremed Recent Developments
Table 110. Key Raw Materials Distribution
Table 111. Raw Materials Key Suppliers
Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 113. Milestones in Production Technology Evolution
Table 114. Distributors List
Table 115. Market Trends and Market Evolution
Table 116. Market Drivers and Opportunities
Table 117. Market Challenges, Risks, and Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Haemostat Product Picture
Figure 2. Global Haemostat Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Pituitrin Product Picture
Figure 4. Hemostatic Sensitivity Product Picture
Figure 5. Others Product Picture
Figure 6. Global Haemostat Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospital
Figure 8. Clinic
Figure 9. ASCs
Figure 10. Others
Figure 11. Haemostat Report Years Considered
Figure 12. Global Haemostat Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Haemostat Revenue (2020-2031) & (US$ Million)
Figure 14. Global Haemostat Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Haemostat Revenue Market Share by Region (2020-2031)
Figure 16. Global Haemostat Sales (2020-2031) & (K Units)
Figure 17. Global Haemostat Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Haemostat Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Haemostat Sales Volume Market Share in 2024
Figure 20. Global Haemostat Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Pituitrin Revenue Market Share by Manufacturer in 2024
Figure 23. Hemostatic Sensitivity Revenue Market Share by Manufacturer in 2024
Figure 24. Others Revenue Market Share by Manufacturer in 2024
Figure 25. Global Haemostat Sales Market Share by Type (2020-2031)
Figure 26. Global Haemostat Revenue Market Share by Type (2020-2031)
Figure 27. Global Haemostat Sales Market Share by Application (2020-2031)
Figure 28. Global Haemostat Revenue Market Share by Application (2020-2031)
Figure 29. North America Haemostat Sales YoY (2020-2031) & (K Units)
Figure 30. North America Haemostat Revenue YoY (2020-2031) & (US$ Million)
Figure 31. North America Top 5 Manufacturers Haemostat Sales Revenue (US$ Million) in 2024
Figure 32. North America Haemostat Sales Volume (K Units) by Type (2020- 2031)
Figure 33. North America Haemostat Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 34. North America Haemostat Sales Volume (K Units) by Application (2020-2031)
Figure 35. North America Haemostat Sales Revenue (US$ Million) by Application (2020-2031)
Figure 36. US Haemostat Revenue (2020-2031) & (US$ Million)
Figure 37. Canada Haemostat Revenue (2020-2031) & (US$ Million)
Figure 38. Mexico Haemostat Revenue (2020-2031) & (US$ Million)
Figure 39. Europe Haemostat Sales YoY (2020-2031) & (K Units)
Figure 40. Europe Haemostat Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Europe Top 5 Manufacturers Haemostat Sales Revenue (US$ Million) in 2024
Figure 42. Europe Haemostat Sales Volume (K Units) by Type (2020-2031)
Figure 43. Europe Haemostat Sales Revenue (US$ Million) by Type (2020-2031)
Figure 44. Europe Haemostat Sales Volume (K Units) by Application (2020-2031)
Figure 45. Europe Haemostat Sales Revenue (US$ Million) by Application (2020-2031)
Figure 46. Germany Haemostat Revenue (2020-2031) & (US$ Million)
Figure 47. France Haemostat Revenue (2020-2031) & (US$ Million)
Figure 48. U.K. Haemostat Revenue (2020-2031) & (US$ Million)
Figure 49. Italy Haemostat Revenue (2020-2031) & (US$ Million)
Figure 50. Russia Haemostat Revenue (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Haemostat Sales YoY (2020-2031) & (K Units)
Figure 52. Asia-Pacific Haemostat Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Top 8 Manufacturers Haemostat Sales Revenue (US$ Million) in 2024
Figure 54. Asia-Pacific Haemostat Sales Volume (K Units) by Type (2020- 2031)
Figure 55. Asia-Pacific Haemostat Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 56. Asia-Pacific Haemostat Sales Volume (K Units) by Application (2020-2031)
Figure 57. Asia-Pacific Haemostat Sales Revenue (US$ Million) by Application (2020-2031)
Figure 58. Indonesia Haemostat Revenue (2020-2031) & (US$ Million)
Figure 59. Japan Haemostat Revenue (2020-2031) & (US$ Million)
Figure 60. South Korea Haemostat Revenue (2020-2031) & (US$ Million)
Figure 61. China Taiwan Haemostat Revenue (2020-2031) & (US$ Million)
Figure 62. India Haemostat Revenue (2020-2031) & (US$ Million)
Figure 63. Central and South America Haemostat Sales YoY (2020-2031) & (K Units)
Figure 64. Central and South America Haemostat Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Central and South America Top 5 Manufacturers Haemostat Sales Revenue (US$ Million) in 2024
Figure 66. Central and South America Haemostat Sales Volume (K Units) by Type (2021-2031)
Figure 67. Central and South America Haemostat Sales Revenue (US$ Million) by Type (2020-2031)
Figure 68. Central and South America Haemostat Sales Volume (K Units) by Application (2020-2031)
Figure 69. Central and South America Haemostat Sales Revenue (US$ Million) by Application (2020-2031)
Figure 70. Brazil Haemostat Revenue (2020-2025) & (US$ Million)
Figure 71. Argentina Haemostat Revenue (2020-2025) & (US$ Million)
Figure 72. Middle East, and Africa Haemostat Sales YoY (2020-2031) & (K Units)
Figure 73. Middle East and Africa Haemostat Revenue YoY (2020-2031) & (US$ Million)
Figure 74. Middle East and Africa Top 5 Manufacturers Haemostat Sales Revenue (US$ Million) in 2024
Figure 75. Middle East and Africa Haemostat Sales Volume (K Units) by Type (2021-2031)
Figure 76. South America Haemostat Sales Revenue (US$ Million) by Type (2020-2031)
Figure 77. Middle East and Africa Haemostat Sales Volume (K Units) by Application (2020-2031)
Figure 78. Middle East and Africa Haemostat Sales Revenue (US$ Million) by Application (2020-2031)
Figure 79. GCC Countries Haemostat Revenue (2020-2025) & (US$ Million)
Figure 80. Turkey Haemostat Revenue (2020-2025) & (US$ Million)
Figure 81. Egypt Haemostat Revenue (2020-2025) & (US$ Million)
Figure 82. South Africa Haemostat Revenue (2020-2025) & (US$ Million)
Figure 83. Haemostat Industry Chain Mapping
Figure 84. Regional Haemostat Manufacturing Base Distribution (%)
Figure 85. Global Haemostat Production Market Share by Region (2020-2031)
Figure 86. Haemostat Production Process
Figure 87. Regional Haemostat Production Cost Structure
Figure 88. Channels of Distribution (Direct Vs Distribution)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
Related Reports
Global Haemostat Market Research Report 2024
The global Haemostat market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 82
USD 2900.00
(Single User License)
Haemostat - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Haemostat was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 98
USD 3950.00
(Single User License)
Global Haemostat Market Insights, Forecast to 2030
The global Haemostat market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-15
Pages: 87
USD 4900.00
(Single User License)
Global Haemostat Market Research Report 2025
The global market for Haemostat was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-25
Pages: 84
USD 2900.00
(Single User License)
Haemostat- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Haemostat was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 96
USD 3950.00
(Single User License)
Global Haemostat Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Haemostat market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 79
USD 4250.00
(Single User License)
Global Haemostat Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Haemostat market is projected to grow from US$ 2150 million in 2025 to US$ 3099 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-05-14
Pages: 177
USD 4900.00
(Single User License)
Global Haemostat Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Haemostat market size was US$ 2150 million in 2025 and is forecast to reach a readjusted size of US$ 3099 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published Date: 2026-05-14
Pages: 150
USD 4250.00
(Single User License)
Haemostat- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Haemostat was estimated to be worth US$ 2150 million in 2025 and is projected to reach US$ 3099 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-05-14
Pages: 146
USD 3950.00
(Single User License)
Global Haemostat Market Research Report 2026
The global Haemostat market was valued at US$ 2150 million in 2025 and is anticipated to reach US$ 3099 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-05-14
Pages: 134
USD 2900.00
(Single User License)
Global Haemostat Market Research Report 2024
The global Haemostat market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 82
USD 2900.00 (Single User License)Haemostat - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Haemostat was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 98
USD 3950.00 (Single User License)Global Haemostat Market Insights, Forecast to 2030
The global Haemostat market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-15
Pages: 87
USD 4900.00 (Single User License)Global Haemostat Market Research Report 2025
The global market for Haemostat was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-25
Pages: 84
USD 2900.00 (Single User License)Haemostat- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Haemostat was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 96
USD 3950.00 (Single User License)Global Haemostat Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Haemostat market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 79
USD 4250.00 (Single User License)Global Haemostat Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Haemostat market is projected to grow from US$ 2150 million in 2025 to US$ 3099 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-05-14
Pages: 177
USD 4900.00 (Single User License)Global Haemostat Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Haemostat market size was US$ 2150 million in 2025 and is forecast to reach a readjusted size of US$ 3099 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published: 2026-05-14
Pages: 150
USD 4250.00 (Single User License)Haemostat- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Haemostat was estimated to be worth US$ 2150 million in 2025 and is projected to reach US$ 3099 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-05-14
Pages: 146
USD 3950.00 (Single User License)Global Haemostat Market Research Report 2026
The global Haemostat market was valued at US$ 2150 million in 2025 and is anticipated to reach US$ 3099 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-05-14
Pages: 134
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
Why This Report?
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research